Tizig Pharma – Effective Generics from India
Tizig
Tizig Pharma Pvt. Ltd. is a Nepalese pharmaceutical company set up with investment from Indian investors. Its corporate office is in Kathmandu and its plant is in Nala, Banepa Municipality, Kavre district. According to the Nepalese press, around NPR 320 million was invested in construction and equipment.
Tizig was the first company to manufacture anti-cancer medicines in Nepal. Its production technology was transferred by SP Accure Labs, an Indian company from Hyderabad. Distribution of the first Nepalese-made cancer medicines began in February 2022, and Nepal's Department of Drug Administration has approved the company to produce 27 anti-cancer molecules. Its medicines are made as tablets and capsules, and the plant produces oncology products only.
Unifarm carries Tizig's targeted medicine Palbotiz (palbociclib), used to treat advanced breast cancer.